Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jelena, Jelicic"'
Autor:
Jelena Jelicic, Karen Juul‐Jensen, Zoran Bukumiric, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Ludvigsen Al‐Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter Brown, Tarec Christoffer El‐Galaly, Thomas Stauffer Larsen
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background Several clinical prognostic models for diffuse large B‐cell lymphoma (DLBCL) have been proposed, including the most commonly used International Prognostic Index (IPI), the National Comprehensive Cancer Network IPI (NCCN‐IPI),
Externí odkaz:
https://doaj.org/article/962bda7300354816a5d7ddb24ee577af
Autor:
Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Peter Brown, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Currently, the International Prognostic Index (IPI) is the most used and reported model for prognostication in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). IPI-like variations have been proposed, but only a few have b
Externí odkaz:
https://doaj.org/article/8b627bc21d06479eb96599fd9fb6c239
Autor:
Kim Oren Gradel, Thomas Stauffer Larsen, Henrik Frederiksen, Pernille Just Vinholt, Maria Iachina, Pedro Póvoa, Fernando Godinho Zampieri, Stig Lønberg Nielsen, Ram Benny Dessau, Jens Kjølseth Møller, Thøger Gorm Jensen, Ming Chen, John Eugenio Coia, Jelena Jelicic
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 713-722 (2022)
Objectives and study design: In this population-based study of 602 patients, we amended C-reactive protein (CRP) and plasma albumin (PA) levels around the diagnosis of diffuse large B-cell lymphoma (DLBCL) to the International Prognostic Index (IPI)
Externí odkaz:
https://doaj.org/article/46234c52ee404cc0898278295c240398
Autor:
Maja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, Henriette Engberg, Pernille Hammershøj Jensen, Helene Bjørg Kristensen, Joachim Baech, Michael Roost Clausen, Anne Ortved Gang, Lars Munksgaard, Tarec Christoffer El-Galaly, Henrik Frederiksen, Thomas Stauffer Larsen
Publikováno v:
Juul, M B, Jelicic, J, Anru, P L, Engberg, H, Hammershøj Jensen, P, Kristensen, H B, Baech, J, Clausen, M R, Gang, A O, Munksgaard, L, El-Galaly, T C, Frederiksen, H & Stauffer Larsen, T 2022, ' Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma : a Danish population-based cohort study ', Leukemia and Lymphoma, vol. 63, no. 9, pp. 2074-2083 . https://doi.org/10.1080/10428194.2022.2064982
Diffuse large B-cell lymphoma is an aggressive disease occurring primarily in elderly patients. Despite high curative rates with doxorubicin-containing treatment, some elderly patients receive less intensive treatments, mainly due to advanced age, co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56dfdfa95a148e725ba93e2083e49b4f
https://doi.org/10.1080/10428194.2022.2064982
https://doi.org/10.1080/10428194.2022.2064982
Autor:
Darko Antic, Jelena Jelicic, Vojin Vukovic, Gordana Pupic, Zorka Milovanovic, Biljana Mihaljevic
Publikováno v:
Dermatologica Sinica, Vol 33, Iss 3, Pp 166-169 (2015)
We present the case of a 69-year-old Caucasian man with a 5-year history of untreated chronic lymphocytic leukemia who presented with Merkel cell carcinoma on the right gluteal region. Six months after surgical treatment of Merkel cell carcinoma, we
Externí odkaz:
https://doaj.org/article/a901b38db4da484eb76869354ea7ec72
Autor:
Ahmed Ludvigsen Al-Mashhadi, Lasse Hjort Jakobsen, Peter de Nully Brown, Anne Ortved Gang, Anne-Luise Thorsteinsson, Kaziwa Rasoul, Judith Melchior Heissmann, Michael Buch Tøstesen, Mette Nieman Christoffersen, Jelena Jelicic, Jennifer Bøgh Jørgensen, Troels Thomsen, Andriette Dessau-Arp, Andreas PH Andersen, Mikael Frederiksen, Per Troellund Pedersen, Michael Roost Clausen, Judit Jørgensen, Christian Bjørn Poulsen, Tarec Christoffer Christoffer El-Galaly, Thomas S. Larsen
Publikováno v:
Al-Mashhadi, A L, Jakobsen, L H, Brown, P D N, Gang, A O, Thorsteinsson, A-L, Rasoul, K, Heissmann, J M, Tøstesen, M B, Christoffersen, M N, Jelicic, J, Jørgensen, J B, Thomsen, T, Dessau-Arp, A, Andersen, A PH, Frederiksen, M, Pedersen, P T, Clausen, M R, Jørgensen, J, Poulsen, C B, El-Galaly, T C C & Larsen, T S 2022, ' Outcome after 3(rd) Line Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study ', Blood, vol. 140, no. Suppl. 1, pp. 6706-6707 . https://doi.org/10.1182/blood-2022-167897
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a1b13b0c64f27e2730e562ddabd31b6
https://vbn.aau.dk/da/publications/4311f0fc-a4b3-40fd-a9c1-2d23aafd1a69
https://vbn.aau.dk/da/publications/4311f0fc-a4b3-40fd-a9c1-2d23aafd1a69
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(11)
Over the years, a rising incidence of liver cirrhosis and lymphoma has been observed. Therefore, the risk of having cirrhosis as a comorbidity increases, thus challenging treatment approaches as data on the management of these patients is lacking. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e41a40dad03af7295d78d3c937ac01
https://pubmed.ncbi.nlm.nih.gov/35948478
https://pubmed.ncbi.nlm.nih.gov/35948478
Publikováno v:
Jelicic, J, Larsen, T S, Maksimovic, M & Trajkovic, G 2019, ' Available prognostic models for risk stratification of diffuse large B cell lymphoma patients : a systematic review ', Critical Reviews in Oncology/Hematology, vol. 133, pp. 1-16 . https://doi.org/10.1016/j.critrevonc.2018.10.006
The International Prognostic Index (IPI) has been used for risk stratification for a long time in diffuse large B cell lymphoma (DLBCL). Based on new clinical and biological prognostic markers, many new prognostic models have been described. This rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4f6e743551687c1d25d826a04636e29
https://doi.org/10.1016/j.critrevonc.2018.10.006
https://doi.org/10.1016/j.critrevonc.2018.10.006
Autor:
Marija Dencic Fekete, Biljana Mihaljevic, Jelica Jovanovic, Darko Antic, Jelena Jelicic, Marko Mitrovic, Jelena Bila, Zoran Bukumiric, Aleksandra Sretenovic, Teodora Peric
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S123-S124
Background Association of any of 2 or ≥3 specific high-risk chromosomal abnormalities (HR-CA: t(4;14), t(14;16), t(14;20) and +1q21) in multiple myeloma (MM) characterizes double or triple hit MM. Aims The aim of study was to evaluate prognostic si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::483d547b163bdb96cc744f7a18a8e29b
https://doi.org/10.1016/s2152-2650(21)02288-6
https://doi.org/10.1016/s2152-2650(21)02288-6
Autor:
Henrik Frederiksen, Milos Maksimovic, Thomas Stauffer Larsen, Jelena Jelicic, Bosko Andjelic, Zoran Bukumiric
Publikováno v:
Jelicic, J, Larsen, T S, Frederiksen, H, Andjelic, B, Maksimovic, M & Bukumiric, Z 2020, ' Statistical challenges in development of prognostic models in diffuse large B-cell lymphoma : Comparison between existing models – A systematic review ', Clinical Epidemiology, vol. 12, pp. 537-555 . https://doi.org/10.2147/CLEP.S244294
Clinical Epidemiology
Jelicic, J, Larsen, T S, Frederiksen, H, Andjelic, B, Maksimovic, M & Bukumiric, Z 2020, ' Statistical challenges in development of prognostic models in diffuse large b-cell lymphoma : Comparison between existing models – A systematic review ', Clinical Epidemiology, vol. 12, pp. 537-555 . https://doi.org/10.2147/CLEP.S244294
Clinical Epidemiology
Jelicic, J, Larsen, T S, Frederiksen, H, Andjelic, B, Maksimovic, M & Bukumiric, Z 2020, ' Statistical challenges in development of prognostic models in diffuse large b-cell lymphoma : Comparison between existing models – A systematic review ', Clinical Epidemiology, vol. 12, pp. 537-555 . https://doi.org/10.2147/CLEP.S244294
Background and Aim: Based on advances in the diagnosis, classification, and management of diffuse large B-cell lymphoma (DLBCL), a number of new prognostic models have been proposed. The aim of this study was to review and compare different prognosti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29328a8076d3fadb1bb2b83110f0507c
https://vbn.aau.dk/ws/files/344113962/Jelicic_et_al_2020_Statistical_challenges_in_development_of_prognostic_models_in_diffuse_large_B_cell_lymphoma.pdf
https://vbn.aau.dk/ws/files/344113962/Jelicic_et_al_2020_Statistical_challenges_in_development_of_prognostic_models_in_diffuse_large_B_cell_lymphoma.pdf